Investigations

Every investigation we've published, newest first — each one built on primary documents and classified under our evidence standard.

Topics Corporations·Government·Institutions·Public Figures·Fraud & Deception·Media
Institutions — 15 July 2024 — 7 min read

Evolent Health: capitation arrangement overbilling

Evolent Health resolved allegations that inaccurate risk score submissions in its capitated care management programs inflated the per-member-per-month payments it received from health plans, resulting in systematic overbilling for the populations it managed.

Read the full report
Institutions — 11 July 2024 — 7 min read

Rite Aid: The DEA Consent Agreement That Found the Pharmacy Chain Dispensing Controlled Substances Without Adequate Pharmacist Verification

A DEA consent agreement with Rite Aid documented a pattern of dispensing controlled substance prescriptions without the pharmacist verification required to confirm legitimacy — failures that allowed opioid prescriptions showing clear red flags of diversion to be filled at the chain's pharmacies across multiple states.

Read the full report
Corporations — 8 July 2024 — 6 min read

Safelite AutoGlass: The Windshield Repair Giant the FTC Investigated Over Insurance Claim Steering Practices

The FTC investigated Safelite AutoGlass over its dual role as the country's largest auto glass repair provider and a major administrator of glass claims for insurance companies — a combination the agency examined for evidence that Safelite steered consumers toward its own repair network in ways that harmed competition and consumer choice.

Read the full report
Corporations — 3 July 2024 — 7 min read

Align Technology: The Invisalign Maker the SEC Found Inflating Revenue Through Channel Stuffing Into Its Dental Provider Network

The SEC charged Align Technology with channel stuffing — shipping excess Invisalign aligner inventory to dental providers beyond actual demand to artificially inflate quarterly revenue figures — finding the practice constituted fraudulent revenue recognition that misled investors about the company's organic growth trajectory.

Read the full report
Corporations — 3 July 2024 — 6 min read

Netsmart: $1.75M behavioral EHR gap resolution

Netsmart Technologies, the leading EHR vendor for behavioral health organizations, paid $1.75 million after a whistleblower documented a gap between the federal EHR certification the company claimed for its platform and the capabilities of the software as deployed to Medicaid-participating providers.

Read the full report
Corporations — 27 June 2024 — 6 min read

Quality Dentrix: EHR gap, $2M resolution

Quality Systems Inc., maker of Dentrix — the dominant dental practice management platform — paid $2 million after a whistleblower alleged its software was sold to dental practices as certified for Medicaid EHR incentive programs when the deployed product did not fully meet the applicable certification criteria.

Read the full report
Corporations — 25 June 2024 — 7 min read

Intellia Therapeutics: The CRISPR Gene Editing Company Whose SEC Disclosure Practices Drew Scrutiny Over Clinical Data Characterization

The SEC examined Intellia Therapeutics' investor communications around clinical data releases for its CRISPR gene editing programs, scrutinizing whether interim trial data was characterized in ways that created materially accurate impressions of the programs' evidentiary strength and risk profile.

Read the full report